^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

emibetuzumab (LY2875358)

i
Company:
Eli Lilly, Innovent Biologics
Drug class:
c-MET inhibitor
Related drugs: